| 摘要 |
This invention relates to predicting a patient's warfarin dose based on the nucleotide at position -1639 of the VKORC1 gene and the genotype of the CYP2C9 gene in that patient. The warfarin dose so predicted can be further adjusted according to the patient's non-genetic factors, e.g., age, body surface area, medical conditions, and use or non-use of certain drugs. |
